UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 981

Sortiert nach

P1148 BASELINE FACTORS ASSOCIATED WITH SUSTAINED VIROLOGIC RESPONSE (SVR) IN PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORS PLUS PEGINTERFERON ALFA-2a (40KD) AND RIBAVIRIN

Journal of hepatology, 2014-04, Vol.60 (1), p.S465-S465

2014

Volltextzugriff (PDF)

A Discrete Adjoint Model for OpenFOAM

Procedia computer science, 2013, Vol.18, p.429-438

2013

Volltextzugriff (PDF)

Use of forward genetic screens to identify genes required for RNA-directed DNA methylation in Arabidopsis thaliana

Cold Spring Harbor Symposia on Quantitative Biology, 2012, Vol.77, p.195-204

2012

Volltextzugriff (PDF)

918 VIROLOGICAL EFFICACY OF BOCEPREVIR (BOC) AND TELAPREVIR (TVR) PLUS PEGINTERFERON alfa-2a (P)/ RIBAVIRIN (R) UNTIL WEEK 12 IN DRUG ADDICTED PATIENTS WITH GT-1 INFECTION: FIRST REAL LIFE REPORT

Journal of hepatology, 2013-04, Vol.58, p.S378-S378

2013

Volltextzugriff (PDF)

871 REAL-WORLD EFFICACY AND SAFETY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY

Journal of hepatology, 2013-04, Vol.58, p.S357-S358

2013

Volltextzugriff (PDF)

P722 PERFORMANCE AND VALUE OF IFN-LAMBDA3 AND IFN-LAMBDA4 GENOTYPING IN PATIENTS WITH CHRONIC HEPATITIS C (CHC) GENOTYPE 2/3 IN A REAL WORLD SETTING

Journal of hepatology, 2014-04, Vol.60 (1), p.S310-S310

2014

Volltextzugriff (PDF)

872 SUBSTANTIAL RENAL IMPAIRMENT IS NOT INFREQUENT IN HCV PATIENTS UNDER TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR

Journal of hepatology, 2013-04, Vol.58, p.S358-S358

2013

Volltextzugriff (PDF)

Design and performance of the South Pole Acoustic Test Setup

Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 2012-08, Vol.683, p.78-90

2012

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled Trial of Interferon Alfa2a With and Without Amantadine as Initial Treatment for Chronic Hepatitis C

Hepatology (Baltimore, Md.), 2000-10, Vol.32 (4), p.835-841

2000

Volltextzugriff (PDF)

BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells

Cell death and differentiation, 2006-07, Vol.13 (7), p.1156-1169

2006

Volltextzugriff (PDF)

APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis

Cell death and differentiation, 2001-04, Vol.8 (4), p.403-410

2001

Volltextzugriff (PDF)

1121 EARLY MARKERS OF METABOLIC SYNDROME ARE ASSOCIATED WITH DISTINCT HCV GENOTYPES, WHILE ABNORMAL GLUCOSE TOLERANCE SUBSTANTIALLY DECREASES THE LIKELIHOOD OF SVR

Journal of hepatology, 2012-04, Vol.56, p.S442-S442

2012

Volltextzugriff (PDF)

Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice

Gene therapy, 2007-01, Vol.14 (2), p.147-161

2007

Volltextzugriff (PDF)

1335 IL28B POLYMORPHISM IN HIV-POSITIVE PATIENTS WITH ACUTE HEPATITIS C

Journal of hepatology, 2011-03, Vol.54, p.S527-S527

2011

Volltextzugriff (PDF)

467 LONGTERM BENEFITS OF SUSTAINED VIROLOGICAL RESPONSE (SVR) IN PATIENTS WITH CHRONIC HEPATITIS C (CHC) VIRUS INFECTION: THE GERMAN LOTOS STUDY

Journal of hepatology, 2011-03, Vol.54, p.S190-S191

2011

Volltextzugriff (PDF)

Decorin gene transfer-mediated suppression of TGF-β synthesis abrogates experimental malignant glioma growth in vivo

Gene therapy, 1998-09, Vol.5 (9), p.1187-1194

1998

Volltextzugriff (PDF)

Sprue (in the adult)

Praxis (Bern. 1994), 2007-12, Vol.96 (50), p.1979

2007

Volltextzugriff (PDF)

BCL-2 family proteins modulate radiosensitivity in human malignant glioma cells

Journal of neuro-oncology, 2002, Vol.56 (1), p.43-49

2002

Volltextzugriff (PDF)

Situs inversus, situs inversus totalis (in adults)

Praxis (Bern. 1994), 2007-05, Vol.96 (18), p.713

2007

Volltextzugriff (PDF)

Expression and functional activity of osteoprotegerin in human malignant gliomas

Acta neuropathologica, 2004-01, Vol.107 (1), p.17-22

2004

Volltextzugriff (PDF)

1172 GENETIC VARIATION IN IL28B RS 12979860 AND RESPONSE TO HCV-SPECIFIC TREATMENT IN HCV/HIV CO-INFECTED PATIENTS

Journal of hepatology, 2010, Vol.52, p.S453-S453

2010

Volltextzugriff (PDF)

Erythema nodosum

Praxis (Bern. 1994), 2007-04, Vol.96 (16), p.621

2007

Volltextzugriff (PDF)

Anorexia nervosa

Praxis (Bern. 1994), 2007-03, Vol.96 (12), p.441

2007

Volltextzugriff (PDF)

An absence of neutrinos associated with cosmic-ray acceleration in γ-ray bursts

Nature (London), 2012-04, Vol.484 (7394), p.351-354

2012

Volltextzugriff (PDF)

Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma

Current pharmaceutical design, 2006, Vol.12 (3), p.341

2006

Volltextzugriff (PDF)

26 – 50 von 981

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(821)
Mit Volltextzugriff
(753)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

P1148 BASELINE FACTORS ASSOCIATED WITH SUSTAINED VIROLOGIC RESPONSE (SVR) IN PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORS PLUS PEGINTERFERON ALFA-2a (40KD) AND RIBAVIRIN

A Discrete Adjoint Model for OpenFOAM

Use of forward genetic screens to identify genes required for RNA-directed DNA methylation in Arabidopsis thaliana

918 VIROLOGICAL EFFICACY OF BOCEPREVIR (BOC) AND TELAPREVIR (TVR) PLUS PEGINTERFERON alfa-2a (P)/ RIBAVIRIN (R) UNTIL WEEK 12 IN DRUG ADDICTED PATIENTS WITH GT-1 INFECTION: FIRST REAL LIFE REPORT

871 REAL-WORLD EFFICACY AND SAFETY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY

P722 PERFORMANCE AND VALUE OF IFN-LAMBDA3 AND IFN-LAMBDA4 GENOTYPING IN PATIENTS WITH CHRONIC HEPATITIS C (CHC) GENOTYPE 2/3 IN A REAL WORLD SETTING

872 SUBSTANTIAL RENAL IMPAIRMENT IS NOT INFREQUENT IN HCV PATIENTS UNDER TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR

Design and performance of the South Pole Acoustic Test Setup

Randomized, Double-Blind, Placebo-Controlled Trial of Interferon Alfa2a With and Without Amantadine as Initial Treatment for Chronic Hepatitis C

BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells

APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis

1121 EARLY MARKERS OF METABOLIC SYNDROME ARE ASSOCIATED WITH DISTINCT HCV GENOTYPES, WHILE ABNORMAL GLUCOSE TOLERANCE SUBSTANTIALLY DECREASES THE LIKELIHOOD OF SVR

Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice

1335 IL28B POLYMORPHISM IN HIV-POSITIVE PATIENTS WITH ACUTE HEPATITIS C

467 LONGTERM BENEFITS OF SUSTAINED VIROLOGICAL RESPONSE (SVR) IN PATIENTS WITH CHRONIC HEPATITIS C (CHC) VIRUS INFECTION: THE GERMAN LOTOS STUDY

Decorin gene transfer-mediated suppression of TGF-β synthesis abrogates experimental malignant glioma growth in vivo

Sprue (in the adult)

BCL-2 family proteins modulate radiosensitivity in human malignant glioma cells

Situs inversus, situs inversus totalis (in adults)

Expression and functional activity of osteoprotegerin in human malignant gliomas

1172 GENETIC VARIATION IN IL28B RS 12979860 AND RESPONSE TO HCV-SPECIFIC TREATMENT IN HCV/HIV CO-INFECTED PATIENTS

Erythema nodosum

Anorexia nervosa

An absence of neutrinos associated with cosmic-ray acceleration in γ-ray bursts

Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma

Suchergebnisse filtern